<DOC>
	<DOC>NCT00922948</DOC>
	<brief_summary>The purpose of this study is to verify the oncological efficacy and safety of cryoablation and radiofrequency ablation for the treatment of small renal tumors.</brief_summary>
	<brief_title>Cryoablation Versus Radiofrequency Ablation for Small Renal Masses</brief_title>
	<detailed_description>By enrolling all patients treated with CA or RFA, this study will document for the first time the safety and the short and long term efficacy of CA compared to RFA as well as provide urologists and decision makers currently unavailable information on CA in Canada.</detailed_description>
	<mesh_term>Kidney Neoplasms</mesh_term>
	<mesh_term>Carcinoma, Renal Cell</mesh_term>
	<criteria>Patients with tumors that progress in size while on a watchful waiting protocol; Patients with multiple tumors; Patients with a tumor in a solitary kidney; Patients with poor renal function and a renal tumor; Patients with significant comorbidities that may benefit from a less invasive approach. Large tumors &gt; 4.0cm; Unable to have a general anesthetic; Unable to comply with followup protocol (i.e., routine CT or MRI and a followup biopsy); Uncorrectable bleeding diathesis; Evidence of metastatic disease.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Radiofrequency ablation</keyword>
	<keyword>Cryosurgery</keyword>
	<keyword>Renal cancers</keyword>
</DOC>